The Exchange had sought clarification from Sakar Healthcare Limited for the quarter ended 30-Sep-2025 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: -1. Financial results submitted is not as per format prescribed under Schedule III of the Companies Act, 2013 or as per Indian Accounting Standard The response of the Company is enclosed.
SAKAR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The NSE had asked Sakar Healthcare Limited to clarify its financial results for the quarter ended 30 September 2025 under Regulation 33 of SEBI's Listing Obligations and Disclosure Requirements. The specific issue was that the financial results submitted did not follow the format prescribed under Schedule III of the Companies Act, 2013, or Indian Accounting Standards. The company has now submitted its response to the exchange, which is enclosed with the filing. This appears to be a routine format-related compliance query rather than a substantive financial discrepancy.
This is a procedural compliance matter and not indicative of financial distress or wrongdoing. Investors should review the company's actual financial results for the quarter to assess performance, as the clarification relates to presentation format rather than the underlying numbers.